Subbarao Vemulapalli

927 total citations
37 papers, 725 citations indexed

About

Subbarao Vemulapalli is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Subbarao Vemulapalli has authored 37 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Subbarao Vemulapalli's work include Eicosanoids and Hypertension Pharmacology (8 papers), Heart Failure Treatment and Management (8 papers) and Peptidase Inhibition and Analysis (7 papers). Subbarao Vemulapalli is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (8 papers), Heart Failure Treatment and Management (8 papers) and Peptidase Inhibition and Analysis (7 papers). Subbarao Vemulapalli collaborates with scholars based in United States, United Kingdom and Finland. Subbarao Vemulapalli's co-authors include Peter J.S. Chiu, Edmund J. Sybertz, R.W. Watkins, Carolyn Foster, Martin F. Haslanger, Maria A. Rivelli, A Barnett, Madhu Chintala, Robert W. Watkins and Barry J.R. Pitts and has published in prestigious journals such as Hypertension, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Subbarao Vemulapalli

37 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subbarao Vemulapalli United States 17 283 219 211 138 114 37 725
Takao Wada Japan 13 119 0.4× 249 1.1× 105 0.5× 111 0.8× 83 0.7× 76 663
Elizabeth Baskin United States 20 602 2.1× 625 2.9× 250 1.2× 82 0.6× 63 0.6× 28 1.2k
Marco Criscuoli Italy 18 121 0.4× 419 1.9× 216 1.0× 62 0.4× 55 0.5× 76 1.0k
Jiro Endo Japan 15 188 0.7× 336 1.5× 135 0.6× 39 0.3× 239 2.1× 68 834
Mitsuhisa Koga Japan 18 291 1.0× 379 1.7× 125 0.6× 145 1.1× 103 0.9× 44 1.1k
Nelson Escobales Puerto Rico 14 229 0.8× 521 2.4× 251 1.2× 32 0.2× 85 0.7× 49 968
Sandra L. Jimmo Canada 10 211 0.7× 416 1.9× 177 0.8× 34 0.2× 28 0.2× 13 670
Masaya Fukuda Japan 16 238 0.8× 229 1.0× 137 0.6× 38 0.3× 130 1.1× 21 802
J A Lawson Australia 13 96 0.3× 152 0.7× 154 0.7× 52 0.4× 126 1.1× 18 613
G Siffert Germany 8 273 1.0× 439 2.0× 144 0.7× 28 0.2× 276 2.4× 8 923

Countries citing papers authored by Subbarao Vemulapalli

Since Specialization
Citations

This map shows the geographic impact of Subbarao Vemulapalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subbarao Vemulapalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subbarao Vemulapalli more than expected).

Fields of papers citing papers by Subbarao Vemulapalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subbarao Vemulapalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subbarao Vemulapalli. The network helps show where Subbarao Vemulapalli may publish in the future.

Co-authorship network of co-authors of Subbarao Vemulapalli

This figure shows the co-authorship network connecting the top 25 collaborators of Subbarao Vemulapalli. A scholar is included among the top collaborators of Subbarao Vemulapalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subbarao Vemulapalli. Subbarao Vemulapalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2002). Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(21). 3149–3152. 29 indexed citations
2.
Vemulapalli, Subbarao & Stan Kurowski. (2001). Phentolamine mesylate relaxes rabbit corpus cavernosum by a nonadrenergic, noncholinergic mechanism. Fundamental and Clinical Pharmacology. 15(1). 1–7. 7 indexed citations
3.
Vemulapalli, Subbarao, et al.. (2000). Sildenafil relaxes rabbit clitoral corpus cavernosum. Life Sciences. 67(1). 23–29. 37 indexed citations
4.
Chiu, Peter J.S., et al.. (1997). Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(4). 463–469. 12 indexed citations
5.
Vemulapalli, Subbarao, Robert W. Watkins, Madhu Chintala, et al.. (1996). Antiplatelet and Antiproliferative Effects of SCH 51866, a Novel Type 1 and Type 5 Phosphodiesterase Inhibitor. Journal of Cardiovascular Pharmacology. 28(6). 862–869. 45 indexed citations
6.
Vemulapalli, Subbarao, et al.. (1996). In vivo Inhibition of Platelet Adhesion by a cGMP-Mediated Mechanism in Balloon Catheter Injured Rat Carotid Artery. Pharmacology. 52(4). 235–242. 9 indexed citations
7.
Vemulapalli, Subbarao, et al.. (1994). Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. European Journal of Pharmacology. 257(1-2). 95–102. 27 indexed citations
8.
Vemulapalli, Subbarao, et al.. (1993). Attenuation of Ischemic Acute Renal Failure by Phosphoramidon in Rats. Pharmacology. 47(3). 188–193. 33 indexed citations
9.
Watkins, R.W., Subbarao Vemulapalli, Peter J.S. Chiu, et al.. (1993). Atrial Natriuretic Factor Potentiating and Hemodynamic Effects of SCH 42495, a New, Neutral Metalloendopeptidase Inhibitor. American Journal of Hypertension. 6(5_Pt_1). 357–368. 7 indexed citations
10.
Chiu, Peter, Subbarao Vemulapalli, & Edmund J. Sybertz. (1991). Comparative Vascular and Renal Excretory Effects of Atrial Natriuretic Factor, Sodium Nitroprusside and 8-BR-cGMP in Spontaneously Hypertensive Rats. Clinical and Experimental Hypertension Part A Theory and Practice. 13(5). 907–915. 1 indexed citations
11.
Sybertz, Edmund J., Peter J.S. Chiu, Robert W. Watkins, & Subbarao Vemulapalli. (1991). Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action. Canadian Journal of Physiology and Pharmacology. 69(10). 1628–1635. 13 indexed citations
12.
Vemulapalli, Subbarao, Peter J.S. Chiu, Maria A. Rivelli, Carolyn Foster, & Edmund J. Sybertz. (1991). Modulation of Circulating Endothelin Levels in Hypertension and Endotoxemia in Rats. Journal of Cardiovascular Pharmacology. 18(6). 895–903. 56 indexed citations
13.
14.
Helin, Kristian, et al.. (1991). Prolonged neutral endopeptidase inhibition in heart failure. European Journal of Pharmacology. 198(1). 23–30. 17 indexed citations
15.
16.
Vemulapalli, Subbarao, et al.. (1986). AGEPC, a vasodilator phospholipid with profound circulatory actions.. PubMed. 219. 133–56. 1 indexed citations
17.
Chiu, Peter, Subbarao Vemulapalli, & A Barnett. (1985). Acute blood pressure and urinary responses to single dose combinations of captopril and diuretics in conscious spontaneously hypertensive rats. Journal of Pharmacy and Pharmacology. 37(2). 105–109. 8 indexed citations
18.
Vemulapalli, Subbarao, Peter J.S. Chiu, & Adrian Barnett. (1984). Cardiovascular and renal action of platelet-activating factor in anesthetized dogs.. Hypertension. 6(4). 489–493. 25 indexed citations
19.
Vemulapalli, Subbarao, et al.. (1983). Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs.. PubMed. 262(1). 109–23. 3 indexed citations
20.
Baum, Thomas, R.W. Watkins, Edmund J. Sybertz, et al.. (1981). Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.. Journal of Pharmacology and Experimental Therapeutics. 218(2). 444–452. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takao Wada Breakdown of academic impact, for papers by Elizabeth Baskin Breakdown of academic impact, for papers by Marco Criscuoli Breakdown of academic impact, for papers by Jiro Endo Breakdown of academic impact, for papers by Mitsuhisa Koga Breakdown of academic impact, for papers by Nelson Escobales Breakdown of academic impact, for papers by Sandra L. Jimmo Breakdown of academic impact, for papers by Masaya Fukuda Breakdown of academic impact, for papers by J A Lawson Breakdown of academic impact, for papers by G Siffert
Rankless by CCL
2026